久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/03 | 3,550 | 3,590 | 3,520 | 3,585 | +70 | +2% | 174,200 |
| 2022/03/02 | 3,585 | 3,595 | 3,505 | 3,515 | -105 | -2.9% | 214,700 |
| 2022/03/01 | 3,650 | 3,665 | 3,605 | 3,620 | -40 | -1.1% | 205,200 |
| 2022/02/28 | 3,540 | 3,660 | 3,540 | 3,660 | +120 | +3.4% | 250,200 |
| 2022/02/25 | 3,600 | 3,620 | 3,515 | 3,540 | -60 | -1.7% | 241,900 |
| 2022/02/24 | 3,535 | 3,600 | 3,505 | 3,600 | +35 | +1% | 340,200 |
| 2022/02/22 | 3,615 | 3,615 | 3,550 | 3,565 | -80 | -2.2% | 172,800 |
| 2022/02/21 | 3,690 | 3,695 | 3,635 | 3,645 | -105 | -2.8% | 113,900 |
| 2022/02/18 | 3,660 | 3,755 | 3,660 | 3,750 | +25 | +0.7% | 164,500 |
| 2022/02/17 | 3,830 | 3,830 | 3,700 | 3,725 | -100 | -2.6% | 190,800 |
| 2022/02/16 | 3,780 | 3,825 | 3,740 | 3,825 | +70 | +1.9% | 247,100 |
| 2022/02/15 | 3,690 | 3,755 | 3,680 | 3,755 | +75 | +2% | 308,400 |
| 2022/02/14 | 3,600 | 3,695 | 3,585 | 3,680 | +10 | +0.3% | 152,500 |
| 2022/02/10 | 3,720 | 3,720 | 3,665 | 3,670 | -20 | -0.5% | 199,700 |
| 2022/02/09 | 3,665 | 3,700 | 3,605 | 3,690 | +15 | +0.4% | 215,400 |
| 2022/02/08 | 3,680 | 3,705 | 3,640 | 3,675 | -5 | -0.1% | 182,900 |
| 2022/02/07 | 3,605 | 3,685 | 3,580 | 3,680 | +45 | +1.2% | 218,100 |
| 2022/02/04 | 3,600 | 3,650 | 3,570 | 3,635 | -25 | -0.7% | 251,600 |
| 2022/02/03 | 3,580 | 3,665 | 3,565 | 3,660 | +25 | +0.7% | 283,700 |
| 2022/02/02 | 3,530 | 3,635 | 3,530 | 3,635 | +130 | +3.7% | 278,600 |
| 2022/02/01 | 3,520 | 3,550 | 3,490 | 3,505 | +30 | +0.9% | 232,700 |
| 2022/01/31 | 3,475 | 3,505 | 3,435 | 3,475 | +45 | +1.3% | 216,500 |
| 2022/01/28 | 3,400 | 3,455 | 3,400 | 3,430 | +95 | +2.8% | 244,400 |
| 2022/01/27 | 3,460 | 3,465 | 3,335 | 3,335 | -120 | -3.5% | 340,000 |
| 2022/01/26 | 3,550 | 3,565 | 3,455 | 3,455 | -135 | -3.8% | 286,400 |
| 2022/01/25 | 3,575 | 3,600 | 3,535 | 3,590 | -10 | -0.3% | 232,700 |
| 2022/01/24 | 3,505 | 3,600 | 3,475 | 3,600 | +75 | +2.1% | 283,100 |
| 2022/01/21 | 3,410 | 3,525 | 3,405 | 3,525 | +80 | +2.3% | 267,200 |
| 2022/01/20 | 3,360 | 3,460 | 3,360 | 3,445 | +45 | +1.3% | 324,100 |
| 2022/01/19 | 3,415 | 3,450 | 3,390 | 3,400 | -70 | -2% | 290,900 |
| 2022/01/18 | 3,565 | 3,620 | 3,470 | 3,470 | -120 | -3.3% | 381,700 |
| 2022/01/17 | 3,650 | 3,660 | 3,575 | 3,590 | -45 | -1.2% | 343,000 |
| 2022/01/14 | 3,830 | 3,855 | 3,620 | 3,635 | -405 | -10% | 845,900 |
| 2022/01/13 | 4,180 | 4,180 | 4,035 | 4,040 | -140 | -3.3% | 333,400 |
| 2022/01/12 | 4,100 | 4,195 | 4,085 | 4,180 | +120 | +3% | 292,200 |
| 2022/01/11 | 4,120 | 4,150 | 4,015 | 4,060 | -25 | -0.6% | 257,600 |
| 2022/01/07 | 4,025 | 4,090 | 4,000 | 4,085 | +105 | +2.6% | 261,800 |
| 2022/01/06 | 4,080 | 4,120 | 3,980 | 3,980 | -135 | -3.3% | 297,600 |
| 2022/01/05 | 4,130 | 4,140 | 4,085 | 4,115 | -25 | -0.6% | 223,700 |
| 2022/01/04 | 4,045 | 4,145 | 4,015 | 4,140 | +165 | +4.2% | 352,900 |
| 2021/12/30 | 4,040 | 4,050 | 3,965 | 3,975 | -100 | -2.5% | 243,600 |
| 2021/12/29 | 4,070 | 4,120 | 4,050 | 4,075 | ±0 | ±0% | 155,400 |
| 2021/12/28 | 4,070 | 4,115 | 4,040 | 4,075 | ±0 | ±0% | 202,800 |
| 2021/12/27 | 4,045 | 4,085 | 3,980 | 4,075 | +30 | +0.7% | 215,500 |
| 2021/12/24 | 4,030 | 4,055 | 3,970 | 4,045 | +25 | +0.6% | 204,000 |
| 2021/12/23 | 4,060 | 4,080 | 4,005 | 4,020 | -35 | -0.9% | 157,800 |
| 2021/12/22 | 4,080 | 4,110 | 4,030 | 4,055 | +30 | +0.7% | 262,800 |
| 2021/12/21 | 3,970 | 4,030 | 3,960 | 4,025 | +85 | +2.2% | 223,900 |
| 2021/12/20 | 4,000 | 4,005 | 3,925 | 3,940 | -65 | -1.6% | 205,700 |
| 2021/12/17 | 4,055 | 4,075 | 4,005 | 4,005 | -80 | -2% | 606,000 |
851～
900
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 429,800円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 143,900円 | -11.0% | +206.6% | 0.00% | 14.29倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 157,600円 | -2.0% | -7.3% | 2.41% | 15.40倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 364,600円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 323,400円 | +3.6% | -15.3% | 3.83% | 9.08倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム
